[The treatment of cyclosporine A-resistant pyoderma gangrenosum with recombinant interferon alfa-2].
Sánchez Román
J
J
Castillo Palma
M J
MJ
Ocaña Medina
C
C
Rodríguez Cañas
T
T
D000328:Adult; D002908:Chronic Disease; D016572:Cyclosporine / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000628:therapy*; D011994:Recombinant Proteins; D012074:Remission Induction
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D016572:Cyclosporine
Tratamiento del pioderma gangrenoso resistente a ciclosporin A con interferón alfa-2 recombinante.